Repositrak CEO Fields sells $122,274 in shares

Published 23/09/2025, 23:44
Repositrak CEO Fields sells $122,274 in shares

Randall K Fields, Chief Executive Officer of ReposiTrak, Inc. (NASDAQ:TRAK), a company with impressive gross profit margins of 83.6% and a market capitalization of $316 million, sold a total of 7,000 shares of common stock on September 22 and 23. The sales, executed under a pre-arranged Rule 10b5-1 trading plan, totaled $122,274. According to InvestingPro analysis, the company maintains strong financial health with more cash than debt on its balance sheet.

On September 22, Fields sold 3,000 shares at a weighted average price of $17.5775, for a total of $52,732.50. The prices for these shares ranged from $17.3534 to $17.65. Following this transaction, RK Fields Charitable 2022, LLC, owns 69,000 shares.

The following day, September 23, Fields sold an additional 4,000 shares at a weighted average price of $17.3856, for a total of $69,542.40. The prices for these shares ranged from $17.17 to $17.60. Following this transaction, RK Fields Charitable 2022, LLC, owns 65,000 shares.

These sales were executed by RK Fields Charitable 2022, LLC, of which Fields is the managing member. The trading plan was established to meet some of his charitable commitments.

Following these transactions, Fields directly owns 3,683,955 shares of ReposiTrak common stock. He also indirectly owns 615,260 shares through Riverview Financial Corp., 30,667 shares through his spouse, 333,643 shares through Fields Management, Inc., 531,432 shares of Series B Preferred Stock through Riverview Financial Corp and 12,322 shares of Series B Preferred Stock through his spouse.

In other recent news, ReposiTrak, Inc. announced a quarterly dividend of $0.02 per share, payable to shareholders of record on September 30, 2025, with distribution expected around November 14, 2025. This marks the third increase in the company’s dividend since its inception. In addition, ReposiTrak is expanding its Traceability Network with the inclusion of 30 cheese suppliers, enhancing its capabilities to exchange FDA-required Key Data Elements for Critical Tracking Events. This move is in response to growing retailer demands for food safety and transparency. Furthermore, the company has added 20 specialty food suppliers to its network, including a vegan cheese supplier and a direct-to-consumer snack provider. Another significant development is the addition of 31 global cheese suppliers to the network, including a major Australian cheese manufacturer. These strategic expansions underscore ReposiTrak’s commitment to improving food traceability and safety.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.